/PRNewswire/ PM360, the premier information resource for marketing decision makers in the pharmaceutical, biotech, diagnostics, and medical device sectors,.
2022 JAN 13 By a News Reporter-Staff News Editor at Insurance Daily News Deepintent Inc. has been issued patent number 11210424, according to news reporting originating out of Alexandria, Virginia, by NewsRx editors. The patent’ s inventors are Dakic, Vaso, Gerritz, Kelly Harold Patrick, Paquette, Christopher Thomas, Perlman, Jennifer Werther, Romanovski, Pavel,.
DeepIntent® Launches DeepIntent Outcomes™
Industry s First Demand-Side Platform Integrated with Real-World Clinical Data to Increase Script Lift, Improving Business Outcomes for Healthcare Marketers
Beta leading pharmaceutical brand experienced an average script lift rise of 10-35% by connecting patient and healthcare provider campaigns
News provided by
Share this article
Share this article
NEW YORK, April 6, 2021 /PRNewswire/ DeepIntent, the leading healthcare marketing technology company built purposefully to influence patient health and business outcomes, today announced DeepIntent Outcomes, which dramatically improves script lift attributed to digital advertising through the use of real-world clinical data. Built into its Healthcare Demand-Side Platform (DSP), DeepIntent Outcomes enables marketers to measure and automatically optimize live campaigns based on script performance from pharmacy claims data that is refreshed daily.